Cardiothoracic Surgery in Boise, ID
5 verified cardiothoracic surgery doctors in Boise.
Cardiothoracic surgeons operate on the heart, lungs, and other organs in the chest.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Dr. Russell Griffiths, MD
Cardiothoracic Surgery
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Craig Bass, MD
Cardiothoracic Surgery
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Linsey Etherington, MD
Cardiothoracic Surgery
CMS Open Payments· $315.20 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$315.20
Total received
6
Transactions
4
Paying companies
Top paying companies
Among the 2,660 cardiothoracic surgery doctors we've analyzed, about 66% received any industry payment (median $331 among those who did). This doctor's total ranks around the 66th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiothoracic surgery doctors.
Payments to Linsey Etherington do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Patrick Cole, MD
Cardiothoracic Surgery
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Lauren Bechtold, MD
Cardiothoracic Surgery
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.